Início › Câncer de Pulmão › Arkansas
Ensaios clínicos de Câncer de Pulmão em Arkansas
19 estudos para Câncer de Pulmão estão buscando participantes em locais em Arkansas.
Cidades em Arkansas
Texto oficial do estudo (Inglês)
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
- NEA Baptist Memorial Hospital and Fowler Family Cancer Center - Jonesboro, Jonesboro
RecrutandoFase 3
Idades 18 e acima · Todos os sexos · Atualizado em 2 de out. de 2026 · NCT04267848Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- Mercy Hospital Fort Smith, Fort Smith
- CARTI Cancer Center, Little Rock
RecrutandoEstudo observacionalVoluntários saudáveis bem-vindos
Idades de 40 a 75 · Todos os sexos · Atualizado em 2 de out. de 2026 · NCT05334069Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE Trial
- Highlands Oncology Group - Fayetteville, Fayetteville
- Mercy Hospital Fort Smith, Fort Smith
- Highlands Oncology Group - Rogers, Rogers
- e mais 1
RecrutandoFase 3
Idades 70 e acima · Todos os sexos · Atualizado em 1 de out. de 2026 · NCT06096844Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer
- NEA Baptist Memorial Hospital and Fowler Family Cancer Center - Jonesboro, Jonesboro
RecrutandoFase 3
Idades 18 e acima · Todos os sexos · Atualizado em 1 de out. de 2026 · NCT04181060Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
- NEA Baptist Memorial Hospital and Fowler Family Cancer Center - Jonesboro, Jonesboro
RecrutandoFase 3
Idades 18 e acima · Todos os sexos · Atualizado em 1 de out. de 2026 · NCT06498635A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019)
- UAMS Winthrop P. Rockefeller Cancer Institute ( Site 0060), Little Rock
- Highlands Oncology Group-Research Department ( Site 0062), Springdale
RecrutandoFase 3
Idades 18 e acima · Todos os sexos · Atualizado em 25 de set. de 2026 · NCT06312137Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
- Highlands Oncology Group, Fayetteville
- Highlands Oncology Group, Rogers
- Highlands Oncology Group, Springdale
RecrutandoFase 3
Idades 18 e acima · Todos os sexos · Atualizado em 25 de set. de 2026 · NCT07222566A Study to Compare the Combination of Navlimetostat (BMS-986504) With Pembrolizumab and Chemotherapy Versus Placebo Plus Pembrolizumab and Chemotherapy in First-line Metastatic Non-small Cell Lung Cancer Participants With Homozygous MTAP Deletion
- Highlands Oncology Group, Springdale
RecrutandoFase 2/3
Idades 18 e acima · Todos os sexos · Atualizado em 23 de set. de 2026 · NCT07063745Neoadjuvant and Adjuvant Treatment in Resectable Non-small Cell Lung Cancer
- Research Site, Little Rock
RecrutandoFase 2
Idades de 18 a 95 · Todos os sexos · Atualizado em 23 de set. de 2026 · NCT05061550BL-M14D1 Plus Atezolizumab vs Standard of Care in First-Line Extensive-Stage Small Cell Lung Cancer (BrenDeLL-Lung01)
- Highlands Oncology Group, Springdale
RecrutandoFase 3
Idades 18 e acima · Todos os sexos · Atualizado em 17 de set. de 2026 · NCT07625644A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
- Highlands Oncology Group, Springdale
RecrutandoFase 3
Idades 18 e acima · Todos os sexos · Atualizado em 8 de set. de 2026 · NCT06119581Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM Trial
- University of Arkansas for Medical Sciences, Little Rock
RecrutandoFase 3
Idades 18 e acima · Todos os sexos · Atualizado em 17 de ago. de 2026 · NCT06500481Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer
- NEA Baptist Memorial Hospital and Fowler Family Cancer Center - Jonesboro, Jonesboro
- University of Arkansas for Medical Sciences, Little Rock
RecrutandoFase 3
Idades 18 e acima · Todos os sexos · Atualizado em 17 de ago. de 2026 · NCT05624996Study Evaluating the Safety and Efficacy of HWK-007, a PTK7-directed Antibody Drug Conjugate in Participants With Advanced Solid Tumors
- University of Arkansas, Little Rock
RecrutandoFase 1
Idades 18 e acima · Todos os sexos · Atualizado em 5 de ago. de 2026 · NCT07444814Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
- NEA Baptist Memorial Hospital and Fowler Family Cancer Center - Jonesboro, Jonesboro
- University of Arkansas for Medical Sciences, Little Rock
RecrutandoFase 2
Idades 18 e acima · Todos os sexos · Atualizado em 3 de jun. de 2026 · NCT05642572Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
- NEA Baptist Memorial Hospital and Fowler Family Cancer Center - Jonesboro, Jonesboro
- University of Arkansas for Medical Sciences, Little Rock
RecrutandoFase 2
18 Minutes · Todos os sexos · Atualizado em 5 de mai. de 2026 · NCT06031688Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
- NEA Baptist Memorial Hospital and Fowler Family Cancer Center - Jonesboro, Jonesboro
RecrutandoFase 2/3
Idades 18 e acima · Todos os sexos · Atualizado em 5 de mai. de 2026 · NCT06616584LOTUS-CC: An Observational Research Study to Uncover Subtypes of Cancer Cachexia
- Mercy Hospital Fort Smith, Fort Smith
RecrutandoEstudo observacional
Idades 18 e acima · Todos os sexos · Atualizado em 9 de jan. de 2026 · NCT06073431SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Little Rock
RecrutandoEstudo observacional
Todas as idades · Todos os sexos · Atualizado em 28 de out. de 2025 · NCT03452774Fonte: ClinicalTrials.gov, dados obtidos em 5 de out. de 2026. Cada estudo define seus próprios critérios de elegibilidade; a equipe do estudo decide quem pode participar.